Webinar Archive

Research Series

ICR Logo Icon PNG

Jane Metrik, Ph.D, Cannabis and Alcohol Co-Use and Comorbidity

ICR Logo Icon PNG

Emily Bates, PhD., Is CBD Consumption During Pregnancy Safe? Postnatal Consequences of CBD Exposure During Gestation

ICR Logo Icon PNG

Tess Eidom PhD, PCQI, Assessing and Addressing Microbial Risks to Cannabis Patients and Consumers

ICR Logo Icon PNG

Ryan Vandrey, PhD., Experimental analysis of acute cannabis and cannabinoid effects in healthy adults

ICR Logo Icon PNG

Dr. Jodi Gilman, Identification of THC Impairment Using Functional Brain Imaging

ICR Logo Icon PNG

Dr. Reinhold Penner, Cannabinoids as Modulators of Calcium and Inflammation

ICR Logo Icon PNG

Dr. Adie Rae Wilson-Poe, The Unintended Negative Impact of Adult-Use Cannabis Legalization on the Wellbeing of Medical Cannabis Patients

March 2023

Dr. Adie Rae Wilson-Poe : “The Unintended Negative Impact of Adult-Use Cannabis Legalization on the Wellbeing of Medical Cannabis Patients” Dr. Wilson-Poe received her BS in Psychology and her PhD in Neuroscience from Washington State University, where she focused on the pain-relieving properties of opioids and cannabinoids.

Adie followed up on this training by taking […]

Read More »
ICR Logo Icon PNG

Dr. Shawn Hauser, Cannabis Legislative and Policy Update

February 2023

Ms. Shawn Hauser is a partner at Vicente Sederberg and co-chair of the firm’s Hemp and Cannabinoids Department as well as a leader in the firm’s psychedelics and emerging therapies practice. Shawn helps cannabis, hemp, and psychedelics businesses navigate the intersections between state and federal law including cannabis and psychedelics laws and food and […]

Read More »
ICR Logo Icon PNG

Dr. Jordan Tishler, Why We Need a More Medical Medical-Cannabis System

January 2023

Dr. Tishler is a Cannabis Specialist. Through his training in Internal Medicine and years of practice as an Emergency Physician, Dr. Tishler brings his knowledge, reason, and caring to patients here at inhale MD, and through his advocacy work at the local and national levels. Dr. Tishler graduated from both Harvard College and Harvard […]

Read More »
ICR Logo Icon PNG

Dr. Cinnamon Bidwell, PhD, Cannabis Psychopharmacology and Harm Reduction: Empirical Investigations Using Legal Market Products

October 2022

Dr. Cinnamon Bidwell’s primary research focus is translational studies investigating the effects of abused drugs and how these effects impact psychological and physical health acutely and chronically. For over a decade, she has been building on her training in studies of drug dependence, neurobehavior, behavioral genetics, and co-occurring psychiatric disorders. She has expertise in […]

Read More »
ICR Logo Icon PNG

Dr. Hollis Karoly, Exploring the Effects of Oral Cannabidiol on Blood Alcohol Level and Intoxication: Results from a Human Laboratory Study

September 2022

Dr. Hollis Karoly is an Assistant Professor at Colorado State University, Fort Collins, Colorado specializing in Clinical Psychology and Neuroscience with a specialization in addictive disorders. Her research aims to characterize neural, molecular and behavioral mechanisms underlying the etiology of alcohol use disorders, in an effort to inform treatment development. More specifically, Dr. Karoly […]

Read More »
ICR Logo Icon PNG

Dr. Cecilia Hillard, The role of endocannabinoid signaling in the regulation of mood and responses to stress

July 2022

Professor Cecilia Hillard is the Director of the Neuroscience Research Center and Associate Dean for Research at the Medical College of Wisconsin. As a highly active researcher, Dr. Hillard’s laboratory primarily focuses on the pharmacology and biochemistry of cannabinoids and endocannabinoids. Her research focuses on cannabinoids, the receptors with which they interact, and the […]

Read More »
ICR Logo Icon PNG

Dr. Tory Spindle, Using human laboratory studies to advance cannabis regulatory science

May 2023

Dr. Tory Spindle obtained his PhD in Experimental Health Psychology from Virginia Commonwealth University. Broadly, Dr. Spindle utilizes human laboratory studies to characterize the behavioral pharmacology of cannabis and individual cannabis constituents. His research seeks to understand how factors such as route of administration (oral, vaped, smoked, topical), dose, product formulation/chemical composition profile, and […]

Read More »
ICR Logo Icon PNG

Dr. Jessica S. Kruger, The Alphabet Soup of Alternative Cannabinoids

April 2023

Jessica S. Kruger, PhD, MCHES, is a health educator whose research focuses on consumption and addictive behaviors, health behavior decision-making and pedagogy in public health. She collaborates with a wide variety of community-based organizations and advises students at the Lighthouse Free Medical Clinic and the Seneca-Babcock Community Center, both in the Western New York […]

Read More »
ICR Logo Icon PNG

Dr. Marsha Rosner, Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses

April 2022

Dr. Rosner is the Principal Investigator at the Rosner Laboratory and the Charles B. Huggins Professor of the Ben May Department of Cancer Research at the University of Chicago. After receiving her bachelor’s degree in biochemistry from Harvard University, and her Ph.D. degree in biochemistry from the Massachusetts Institute of Technology as a student […]

Read More »
ICR Logo Icon PNG

Dr. Yasmin Hurd, Cannabis and Neurodevelopmental Vulnerability: What do we really know

February 2022

Dr. Yasmin Hurd is the Ward-Coleman Chair of Translational Neuroscience and the Director of the Addiction Institute, where Hurd is the only Black tenure-track basic science professor at Mount Sinai. Hurd holds appointments as faculty of Neuroscience, Psychiatry, Pharmacology and Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City and is globally recognized for her translational research on the underlying neurobiology of substance […]

Read More »
ICR Logo Icon PNG

Dr. Staci Gruber, Medical Cannabis Use: What to Keep in Mind

January 2022

Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s clinical research focuses on the application of neurocognitive models and brain imaging to better characterize risk factors for substance abuse and psychiatric conditions. […]

Read More »